SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-057994
Filing Date
2018-11-07
Accepted
2018-11-07 16:32:47
Documents
69
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv505573_10q.htm 10-Q 450644
2 EXHIBIT 10.1 tv505573_ex10-1.htm EX-10.1 254863
3 EXHIBIT 10.2 tv505573_ex10-2.htm EX-10.2 149984
4 EXHIBIT 31.1 tv505573_ex31-1.htm EX-31.1 8825
5 EXHIBIT 31.2 tv505573_ex31-2.htm EX-31.2 8903
6 EXHIBIT 32.1 tv505573_ex32-1.htm EX-32.1 4128
7 EXHIBIT 32.2 tv505573_ex32-2.htm EX-32.2 4153
  Complete submission text file 0001144204-18-057994.txt   6426897

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nvax-20180930.xml EX-101.INS 1930422
9 XBRL TAXONOMY EXTENSION SCHEMA nvax-20180930.xsd EX-101.SCH 34339
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20180930_cal.xml EX-101.CAL 35060
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20180930_def.xml EX-101.DEF 256304
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20180930_lab.xml EX-101.LAB 317288
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20180930_pre.xml EX-101.PRE 295532
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 181166799
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1